| |
|
|
|
|
Special Offer | Drug Delivery |
|
| |
|
|
|
 |
|
Drug Delivery Peptides -
Special Offer 20% off*
*Valid through Mar 31, 2007. Please refer to order code MTJFM for getting the discount. |
|
 |
|
| |
|
|
|
Introduction
Efficient transfer of proteins or nucleic acids across cellular membranes is one of the major problems in cell biology. To deliver the functional domain of a selected protein from the outside to the inside of intact cells, a carrier is needed. Cell Permeable Peptides, also known as Protein Transduction Domains (PTDs), are carriers with small peptide domains that can freely cross cell membranes. Several PTDs have been identified that allow a fused protein to efficiently cross cell membranes in a process known as protein transduction. Studies have demonstrated that a TAT peptide derived from the HIV TAT protein has the ability to transduce peptides or proteins into various cells. PTDs have been utilized in anticancer strategy, for example, a cell permeable Bcl-2 binding peptide, cpm1285, shows activity in slowing human myeloid leukemia growth in mice. Cell-permeable phosphopeptides, such as FGFR730pY, which mimics receptor binding sites for specific SH2 domain-containing proteins are potential tools for cancer research and cell signaling mechanism studies.
References
Embury, J. et al. Diabetes 50, 1706 (2001), Wang, H. et al. J. Clin. Invest. 109, 1463 (2002); Lin, Y-Z. J. Biol. Chem. 270, 14255 (1995); Holzberg, D. et al. J. Biol. Chem. 278, 40213 (2003); Williams, E. et al. J. Biol. Chem. 272, 22349 (1997); Nakatani, KH. et al. Nat. Med. 10, 1128 (2004); Mortlock, A. et al. Nucleic Acids Res. 31, e152 (2003); Kaneto, H. et al. Nat. Med. 10, 1128 (2004); Wang, JL. et al. Cancer Res. 60, 1498 (2000); Oess S. and E. Hildt, Gene. Ther. 7, 750 (2000); Dunican, D. et al. Cell Growth Diff. 12, 255 (2001). |
|
|
| |
|
|
|
|
Click on the respective order # to download a detailed data sheed. All prices are euro prices excluding shipment and VAT.
Please refer to order code MTJFM for getting the discount. |
| Order # |
Product |
Unit Size |
List Price |
Offer Price |
| Peptides/Cell Permeable/Drug Delivery Peptides |
| 61204AS |
(Arg)9 |
1 mg |
38,00 |
30,40 |
| 61207AS |
(Arg)9; FAM-labeled |
1 mg |
152,00 |
121,60 |
| 61208AS |
(Arg)9; TAMRA-labeled |
1 mg |
167,00 |
133,60 |
| 60171-1AS |
Aminopeptidase N Ligand (CD13); NGR peptide |
1 mg |
113,00 |
90,40 |
| 60171-5AS |
Aminopeptidase N Ligand (CD13); NGR peptide |
5 mg |
452,00 |
361,60 |
| 61376AS |
Antennapedia Leader Peptide (CT) |
1 mg |
64,00 |
51,20 |
| 61032AS |
Antennapedia Peptide; acid |
1 mg |
61,00 |
48,80 |
| 61033AS |
Antennapedia Peptide; amide |
1 mg |
61,00 |
48,80 |
| 24177AS |
Anti-BetaGamma (MPS-Phosducin-like protein C terminus) |
0.5 mg |
226,00 |
180,80 |
| 24178AS |
Anti-BetaGamma (MPS-Phosducin-like protein C terminus) |
1 mg |
407,00 |
325,60 |
| 61209AS |
Biotin-TAT (47-57) |
1 mg |
72,00 |
57,60 |
| 61255AS |
Buforin |
1 mg |
110,00 |
88,00 |
| 61034AS |
Cys(Npys) Antennapedia Peptide; amide |
1 mg |
72,00 |
57,60 |
| 61205AS |
Cys(Npys)-(Arg)9 |
1 mg |
152,00 |
121,60 |
| 61206AS |
Cys(Npys)-(D-Arg)9 |
1 mg |
182,00 |
145,60 |
| 61214AS |
Cys(Npys)-TAT (47-57) |
1 mg |
152,00 |
121,60 |
| 61213AS |
Cys(Npys)-TAT (47-57); FAM-labeled |
1 mg |
182,00 |
145,60 |
| 61212AS |
Cys-TAT (47-57) |
1 mg |
61,00 |
48,80 |
| 24175AS |
FITC-LC-Antennapedia Peptide |
0.5 mg |
141,00 |
112,80 |
| 24176AS |
FITC-LC-Antennapedia Peptide |
1 mg |
226,00 |
180,80 |
| 24188AS |
FITC-LC-MTS |
0.5 mg |
226,00 |
180,80 |
| 29851AS |
FITC-LC-MTS |
1 mg |
407,00 |
325,60 |
| 27042AS |
FITC-LC-TAT (47-57) |
0.5 mg |
141,00 |
112,80 |
| 27043AS |
FITC-LC-TAT (47-57) |
1 mg |
226,00 |
180,80 |
| 24270AS |
Mastoparan |
1 mg |
45,00 |
36,00 |
| 24269AS |
Mastoparan |
5 mg |
181,00 |
144,80 |
| 60185-1AS |
MEK1 Derived Peptide Inhibitor 1 |
1 mg |
73,00 |
58,40 |
| 60185-5AS |
MEK1 Derived Peptide Inhibitor 1 |
5 mg |
294,00 |
235,20 |
| 61218AS |
Membrane-Permeable Sequence; MPS |
1 mg |
61,00 |
48,80 |
| 60633AS |
MPG; HIV related |
1 mg |
227,00 |
181,60 |
| 61216AS |
MPS-Gai2 |
1 mg |
125,00 |
100,00 |
| 61217AS |
MPS-Galphai3 |
1 mg |
125,00 |
100,00 |
| 60186-1AS |
Myristoyl-MEK1 Derived Peptide Inhibitor 1 |
1 mg |
119,00 |
95,20 |
| 60186-5AS |
Myristoyl-MEK1 Derived Peptide Inhibitor 1 |
5 mg |
475,00 |
380,00 |
| 60189-1AS |
NGR Peptide 1 |
1 mg |
220,00 |
176,00 |
| 60189-5AS |
NGR Peptide 1 |
5 mg |
881,00 |
704,80 |
| 60190-1AS |
NGR Peptide 2 |
1 mg |
107,00 |
85,60 |
| 60190-5AS |
NGR Peptide 2 |
5 mg |
429,00 |
343,20 |
| 60191-1AS |
NGR Peptide 3 |
1 mg |
113,00 |
90,40 |
| 60191-5AS |
NGR Peptide 3 |
5 mg |
452,00 |
361,60 |
| 60192-1AS |
NGR Peptide 4 |
1 mg |
209,00 |
167,20 |
| 60192-5AS |
NGR Peptide 4 |
5 mg |
836,00 |
668,80 |
| 61257AS |
Nuclear Localiation Signal Peptide |
1 mg |
45,00 |
36,00 |
| 61253AS |
Pep-1: Chariot (Non-Covalent Delivery of Peptides and Proteins) |
1 mg |
110,00 |
88,00 |
| 60187-1AS |
Stearyl-MEK-1 Derived Peptide Inhibitor 1; amide |
1 mg |
119,00 |
95,20 |
| 60187-5AS |
Stearyl-MEK-1 Derived Peptide Inhibitor 1; amide |
5 mg |
475,00 |
380,00 |
| 61254AS |
SynB1 |
1 mg |
72,00 |
57,60 |
| 60023-1AS |
TAT (47-57) |
1 mg |
85,00 |
68,00 |
| 60023-5AS |
TAT (47-57) |
5 mg |
339,00 |
271,20 |
| 61215AS |
TAT (47-57) GGG-Cys(Npys) |
1 mg |
152,00 |
121,60 |
| 61210AS |
TAT (47-57); FAM-labeled |
1 mg |
129,00 |
103,20 |
| 61211AS |
TAT (47-57); TAMRA-labeled |
1 mg |
144,00 |
115,20 |
| 61256AS |
Transportan |
1 mg |
148,00 |
118,40 |
|
| |
|
Download Drug Delivery Peptides Flyer (117 kb)
|
|
|
| |
|
|
|
|
| |
|
 |
|
|
| |
|
|
|
|
| |
| |
|
|
|
|
|